Syntab Therapeutics is a German biotech company that develops an immuno-oncology therapy which employs the innate immune system to kill cancer cells highly effectively and to provide long-lasting anti-cancer benefits to patients. The company uses small, completely chemically derived molecules called Immune System Engagers (ISErs).
www.syntab-therapeutics.com